BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30219077)

  • 1. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
    Sun L; Feng L; Cui J
    Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2/Stat3 signaling.
    Liu H; Wang M; Liang N; Guan L
    Turk J Gastroenterol; 2019 Aug; 30(8):722-731. PubMed ID: 31418417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
    Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
    Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
    Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
    J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.
    Yao RR; Li JH; Zhang R; Chen RX; Wang YH
    World J Surg Oncol; 2018 Jan; 16(1):9. PubMed ID: 29338742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RPN2 promotes metastasis of hepatocellular carcinoma cell and inhibits autophagy via STAT3 and NF-κB pathways.
    Huang L; Jian Z; Gao Y; Zhou P; Zhang G; Jiang B; Lv Y
    Aging (Albany NY); 2019 Sep; 11(17):6674-6690. PubMed ID: 31481647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of claudin-12 promotes the metastatic phenotype of human bronchial epithelial cells and is associated with poor prognosis in lung squamous cell carcinoma.
    Sun L; Feng L; Cui J
    Exp Ther Med; 2019 Jan; 17(1):165-174. PubMed ID: 30651778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Lu P; Ding Q; Li X; Ji X; Li L; Fan Y; Xia Y; Tian D; Liu M
    EBioMedicine; 2019 Oct; 48():100-116. PubMed ID: 31597595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
    Gong QZ; Xiao D; Gong GY; Xu J; Wen XD; Feng F; Qu W
    Curr Cancer Drug Targets; 2019; 19(7):583-593. PubMed ID: 30585547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight junction protein CLDN17 serves as a tumor suppressor to reduce the invasion and migration of oral cancer cells by inhibiting epithelial-mesenchymal transition.
    Xu YN; Deng MS; Liu YF; Yao J; Xiao ZY
    Arch Oral Biol; 2022 Jan; 133():105301. PubMed ID: 34781072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression.
    Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
    Tang C; Feng W; Bao Y; Du H
    Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin/STAT3 pathway in hepatocellular carcinoma.
    Wang G; Zhou H; Gu Z; Gao Q; Shen G
    Oncol Rep; 2018 Aug; 40(2):979-987. PubMed ID: 29901157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
    Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J
    Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of intratumour inflammatory cytokine mRNA levels of hepatocellular carcinoma patients and activation of two distinct pathways govern IL-8 induced epithelial-mesenchymal transition in human hepatic cancer cell lines.
    Peng S; Chen Y; Gong Y; Li Z; Xie R; Lin Y; Zou B; Li J; Zeng L
    Cytokine; 2019 Jul; 119():81-89. PubMed ID: 30903867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ; Sui MH; Sun ZX; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.